Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae

By sjmartinez • August 5, 2023

Maas L, Gao R, Cusumano V, Spartz E, Chowdhury R, Krishna M, Lazarev M, Melia J, Selaru F, Sharma S, Limketkai B, Parian A. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn's Perianal Fistulae. Dig Dis Sci. 2023 Aug 4. doi: 10.1007/s10620-023-08060-7. Epub ahead of print. PMID: 37540392.

Tags: Crohn’s disease, Digestive Diseases, General Internal Medicine, inflammatory bowel disease, Perianal disease, Perianal fistula, Publications, Resident, Tumor necrosis factor inhibitor

Collagenous Gastritis Presenting as Chronic Nausea and Vomiting

Shahrvini B, Greb AC, Wang HL, Tripathi PV, Weiss GA, Myint A. Collagenous Gastritis Presenting as Chronic Nausea and Vomiting. ACG Case Rep J. 2026[...]

Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study

Tincopa M, Bridi L, Vodkin I, Yilma M, Zhou K, Kwong A, Singh J, Mehta N, Kuo A, Hirose R, Wisel SA, Steggerda JA, Freise[...]

Irritable bowel syndrome and related disorders of gut-brain interaction

Black CJ, Chuah KH, Nasser Y, Remes-Troche JM, Shin A, Ford AC. Irritable bowel syndrome and related disorders of gut-brain interaction. Lancet. 2026 Oct 29:S0140-6736(26)01500-X.[...]